Among Sinonasal Tumors, CDX-2 Immunoexpression is not Restricted to Intestinal-Type Adenocarcinomas

Head and Neck Pathology

Volumn 8, Issue 1, 2014, Pages 59-65

  Tilson, Matthew P ^a   Gallia, Gary L ^a   Bishop, Justin A ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CDX 2; Cytokeratin 20; Sinonasal adenocarcinoma; Sinonasal undifferentiated carcinoma

Indexed keywords

CDX 2 3 PROTEIN; CDX-2-3 PROTEIN; HOMEODOMAIN PROTEIN; TRANSACTIVATOR PROTEIN; TUMOR MARKER;

ADENOCARCINOMA; ARTICLE; BIOSYNTHESIS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PARANASAL SINUS TUMOR; PATHOLOGY; RETROSPECTIVE STUDY;

ADENOCARCINOMA; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; PARANASAL SINUS NEOPLASMS; RETROSPECTIVE STUDIES; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84897665600     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-013-0475-7     Document Type: Article

References (30)

1. Franchi A, Santucci M, Wenig BM. Intestinal-type adenocarcinomas. In: Barnes L, Eveson JW, Reichart P, Sidranksy D, editors. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005. p. 20-2.
2. Franchi A, Gallo O, Santucci M. Clinical relevance of the histological classification of sinonasal intestinal-type adenocarcinomas. Hum Pathol. 1999;30(10): 1140-5.
3. Barnes L. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol. 1986;10(3): 192-202.
4. Urso C, Ninu MB, Franchi A, Paglierani M, Bondi R. Intestinal-type adenocarcinoma of the sinonasal tract: a clinicopathologic study of 18 cases. Tumori. 1993;79(3): 205-10.
5. Stelow EB, Mills SE. Neural, neuroectodermal, and neuroendocrine neoplasms. Biopsy interpretation of the upper aerodigestive tract and ear. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 149.
6. Franquemont DW, Fechner RE, Mills SE. Histologic classification of sinonasal intestinal-type adenocarcinoma. Am J Surg Pathol. 1991;15(4): 368-75.
7. Kleinsasser O, Schroeder HG. Adenocarcinomas of the inner nose after exposure to wood dust. Morphological findings and relationships between histopathology and clinical behavior in 79 cases. Arch Otorhinolaryngol. 1988;245(1): 1-15.
8. Franchi A, Fondi C, Paglierani M, Pepi M, Gallo O, Santucci M. Epidermal growth factor receptor expression and gene copy number in sinonasal intestinal type adenocarcinoma. Oral Oncol. 2009;45(9): 835-8. doi: 10. 1016/j. oraloncology. 2008. 12. 005.
9. Szablewski V, Solassol J, Poizat F, Larrieux M, Crampette L, Mange A, et al. EGFR Expression and KRAS and BRAF Mutational Status in Intestinal-Type Sinonasal Adenocarcinoma. Int J Mol Sci. 2013;14(3): 5170-81. doi: 10. 3390/ijms14035170.
10. Garcia-Inclan C, Lopez F, Perez-Escuredo J, Cuesta-Albalad MP, Vivanco B, Centeno I, et al. EGFR status and KRAS/BRAF mutations in intestinal-type sinonasal adenocarcinomas. Cell Oncol (Dordr). 2012;35(6): 443-50. doi: 10. 1007/s13402-012-0103-7.
11. Health. NIfOSa. Health effects of exposure to wood dust: a summary of the literature. Washington, D. C.: U. S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, Division of Standards Development and Technology Transfer; 1987.
12. Kleinsasser O, Schroeder HG, Mayer-Brix J. Preinvasive stages of adenocarcinoma of the nose after exposure to wood dust. Eur Arch Otorhinolaryngol. 1991;248(4): 222-9.
13. d'Errico A, Pasian S, Baratti A, Zanelli R, Alfonzo S, Gilardi L, et al. A case-control study on occupational risk factors for sino-nasal cancer. Occup Environ Med. 2009;66(7): 448-55. doi: 10. 1136/oem. 2008. 041277.
14. Bonneterre V, Deschamps E, Persoons R, Bernardet C, Liaudy S, Maitre A, et al. Sino-nasal cancer and exposure to leather dust. Occup Med (Lond). 2007;57(6): 438-43. doi: 10. 1093/occmed/kqm050.
15. Cathro HP, Mills SE. Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2. Am J Surg Pathol. 2004;28(8): 1026-32.
16. Franchi A, Massi D, Baroni G, Santucci M. CDX-2 homeobox gene expression. Am J Surg Pathol. 2003;27(10): 1390-1.
17. Franchi A, Massi D, Palomba A, Biancalani M, Santucci M. CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract. Virchows Archiv Int J pathol. 2004;445(1): 63-7. doi: 10. 1007/s00428-004-1030-4.
18. Kennedy MT, Jordan RC, Berean KW, Perez-Ordonez B. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol. 2004;57(9): 932-7. doi: 10. 1136/jcp. 2004. 016964.
19. Ortiz-Rey JA, Alvarez C, San Miguel P, Iglesias B, Anton I. Expression of CDX2, cytokeratins 7 and 20 in sinonasal intestinal-type adenocarcinoma. Appl Immunohistochem Mol Morphol. 2005;13(2): 142-6.
20. Werling RW, Yaziji H, Bacchi CE, Gown AM. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27(3): 303-10.
21. Bishop JA, Guo TW, Smith DF, Wang H, Ogawa T, Pai SI, et al. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol. 2013;37(2): 185-92. doi: 10. 1097/PAS. 0b013e3182698673.
22. Barnes L, Tse LLY, Hunt JL, Brandwein-Gensler M, Curtin HD, Boffetta P. Tumours of the nasal cavity and paranasal sinuses: introduction. In: Barnes L, Eveson JW, Reichart P, Sidranksy D, editors. World Health Organization classification of tumours: Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005. p. 12-5.
23. Scholl C, Bansal D, Dohner K, Eiwen K, Huntly BJ, Lee BH, et al. The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis. J Clin Investig. 2007;117(4): 1037-48. doi: 10. 1172/JCI30182.
24. Riedt T, Ebinger M, Salih HR, Tomiuk J, Handgretinger R, Kanz L, et al. Aberrant expression of the homeobox gene CDX2 in pediatric acute lymphoblastic leukemia. Blood. 2009;113(17): 4049-51. doi: 10. 1182/blood-2008-12-196634.
25. Wani Y, Notohara K, Saegusa M, Tsukayama C. Aberrant Cdx2 expression in endometrial lesions with squamous differentiation: important role of Cdx2 in squamous morula formation. Hum Pathol. 2008;39(7): 1072-9. doi: 10. 1016/j. humpath. 2007. 07. 019.
26. Bongiovanni M, Piana S, Frattini M, Giovanella L, Spitale A, Ragazzi M, et al. CDX2 expression in columnar variant of papillary thyroid carcinoma. Thyroid. 2013;. doi: 10. 1089/thy. 2013. 0146.
27. Sujoy V, Pinto A, Nose V. Columnar cell variant of papillary thyroid carcinoma: a study of 10 cases with emphasis on CDX2 expression. Thyroid. 2013;23(6): 714-9. doi: 10. 1089/thy. 2012. 0455.
28. Cameselle-Teijeiro J, Alberte-Lista L, Peteiro-Gonzalez D, Abdulkader-Nallib I, Reyes-Santias R, Soares P et al. CDX2 expression in some variants of papillary thyroid carcinoma. Am J Clin Pathol. 2012;138(6): 907-9; author reply p. 10. doi: 10. 1309/AJCP1BGCA6MFCNKH.
29. Enriquez ML, Baloch ZW, Montone KT, Zhang PJ, LiVolsi VA. CDX2 expression in columnar cell variant of papillary thyroid carcinoma. Am J Clin Pathol. 2012;137(5): 722-6. doi: 10. 1309/AJCPXE3PUBWVZCGZ.
30. Steininger H, Mueller H, Marquardt L. Aberrant expression of CDX2 in metaplastic and inflammatory epithelium of the urinary bladder. Am J Surg Pathol. 2005;29(9): 1252.